Tag: Inflammatory bowel disease
-
New Study Suggests Microbe Sparks Early Stages of Ulcerative Colitis
Rethinking Ulcerative Colitis: A Microbe-Driven Beginning For decades, scientists have often described ulcerative colitis (UC) as a disease rooted in an overactive immune response or damage to the gut’s epithelial barrier. A new study, however, challenges this traditional view by proposing that the earliest steps of UC might be sparked by a microbial trigger before…
-
Processed Foods Tied to Higher IBD Risk: New Study Highlights Diet’s Role
Processed foods and inflammatory bowel disease: what the latest findings show Inflammatory bowel disease (IBD), which affects millions worldwide, has long puzzled researchers and clinicians seeking to understand the role of diet in its onset and progression. In 2019, about 4.9 million people worldwide were living with IBD, a number that underscores the global impact…
-
Ultra-Processed Foods Linked to Higher IBD Risk: What It Means for Diet and Health
New evidence links ultra-processed foods to higher IBD risk Inflammatory bowel disease (IBD) affects millions worldwide, with about 4.9 million people living with the condition in 2019. While genetics, gut microbiota, and immune responses have long been tied to IBD, recent research is turning attention to dietary patterns—specifically ultra-processed foods—and how they may influence disease…
-
Innovative Approaches Target PAR2 Receptor to Alleviate Gut Pain
New Avenues in the Fight Against Gut Pain Abdominal pain is a defining feature of many digestive disorders, including inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). As researchers search for treatments that specifically address gut pain, two complementary lines of evidence are emerging. First, a newly identified bacterial enzyme may regulate pain signaling…
-
Targeting PAR2: Innovative Pathways to Relieve Gut Pain
New Insights into a gut pain signaling axis Abdominal pain is a common thread across many digestive disorders, from inflammatory bowel disease (IBD) to irritable bowel syndrome (IBS). Recent research has zeroed in on PAR2, a receptor located on the gut lining and pain-sensing nerves, as a pivotal driver of gut pain. PAR2 becomes activated…
-
AI helps Ont. researcher discover breakthrough antibiotic treatment for bowel disease
Ontario researchers leverage AI to advance Crohn’s and IBD treatment In a notable example of how artificial intelligence is accelerating medical progress, a McMaster University team, in collaboration with researchers from the Massachusetts Institute of Technology, has used AI to identify a promising new antibiotic treatment for Crohn’s disease and inflammatory bowel disease (IBD). The…
-
AI Helps Ont. Researcher Discover Breakthrough Antibiotic Treatment for Bowel Disease
Overview An Ontario university-led collaboration has turned heads in the medical community by using artificial intelligence to advance an antibiotic treatment for Crohn’s disease and inflammatory bowel disease (IBD). McMaster University researchers, led by Jon Stokes and working with partners at the Massachusetts Institute of Technology (MIT), say their AI-driven approach could shorten development time…
-
AI breakthrough antibiotic for Crohn’s disease in Ontario
Ontario researchers leverage AI to forge new path in antibiotic therapy A McMaster University team, led by researcher Jon Stokes and in collaboration with partners at the Massachusetts Institute of Technology, has used artificial intelligence to identify a potential antibiotic treatment for Crohn’s disease and other inflammatory bowel diseases (IBD). The breakthrough, described by Stokes…